Follow-up study for Ro/SSA and La/SSB antibodies
Part of Immune system & allergy clinical trials.
This study follows people who have tested positive for Ro/SSA or La/SSB antibodies (proteins linked to certain autoimmune conditions). It also includes a control group of people without these antibodies or any rheumatologic disease. The goal is to learn more about long-term health patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can read and understand Swedish.
- You must be able to consent for yourself.
- You have no major infection or severe illness that would make participation unsafe.
- You either have tested positive for Ro/SSA or La/SSB antibodies, or you have no rheumatologic disease and no such antibodies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with primary Sjögren's syndrome who have had a blood test for a specific antibody called anti-Ro52. The goal is to understand how antibody levels relate to the disease course and help predict outcomes.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
This study looks at an immune reaction (called anti-Ro/SSA IgE) to see how active primary Sjögren’s disease is. It may help doctors better understand what’s driving symptoms and activity levels over time.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This study follows people with certain rheumatologic conditions over time to learn more about how these diseases progress and how treatments affect them. It involves regular check-ups, surveys, and sample collection.
This study will follow people with adult-onset Still's disease or similar autoinflammatory conditions to learn more about these illnesses over time. By participating, you can help doctors better understand and treat these conditions.
Hear when a new Autoantibodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.